the future of clinically relevant dissolution testing and physiologically based biopharmaceutics...
Published 2 years ago • 264 plays • Length 31:19Download video MP4
Download video MP3
Similar videos
-
59:31
gastroplus, pbbm/pkpd to define dissolution safe space in support of registration specifications
-
1:20:40
mechanistic in vitro dissolution pbpk models to drive drug development
-
1:25:10
quality and biopharmaceutics - use of absorption modeling
-
1:29:50
applying gastroplus modeling establish level a ivivcs waive biostudies
-
1:16:28
physiology based pharmacokinetic modeling in generic drug development and regulatory decisions
-
59:39
physiologically based pharmacokinetic modelling for first‑in‑human predictions
-
1:05:05
utilization of pbbm/pbpk models for building a safe space and regulatory applications in support of
-
1:29
dddplus™ 6: software for the in vitro dissolution experiment of pharmaceutical dosage forms
-
23:43
simcyp biopharm demo - tacrolimus asd
-
1:04:33
drug development update
-
6:55
dmf section 3.2.s.7 - stability
-
1:22:08
use of oral absorption modelling to characterize drug release and absorption of a bcs ii...
-
1:03:59
dddplus™ v6 webinar: in vitro dissolution... reimagined
-
2:03
simulations plus july 2018 events
-
1:23:40
applications of gastroplus pbpk modeling at the fda office of generic drugs
-
1:19:00
reimagine the in vitro dissolution experiment with dddplus 5.0...
-
1:00:57
regulatory roundtable: development and validation of pbbm safe space from the regulatory perspective
-
1:29:02
development of a unified dissolution and precipitation model
-
20:09
the role of modeling and simulation in the approval of generic drug products
-
54:36
part 2 utilization of pbbm pbpk models for building a safe space with dr sandra suarez sharp
-
1:23:31
gastroplus pbpk modeling tool ensure target performance generic product
-
58:18
unlocking the power of pbpk modeling: pbpk for first-in-human and beyond